Beranda › Karsinoma Sel Skuamosa Esofagus
Uji klinis Karsinoma Sel Skuamosa Esofagus yang merekrut di AS
34 studi untuk Karsinoma Sel Skuamosa Esofagus merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Arlington, VA14 studi
- Nashville, TN12 studi
- Houston, TX12 studi
- Los Angeles, CA11 studi
- Baldwin Park, CA8 studi
- West Valley City, UT7 studi
- San Antonio, TX7 studi
- New York City, NY7 studi
- Santa Monica, CA6 studi
- Queens, NY6 studi
- Dallas, TX5 studi
- Orlando, FL5 studi
- Boston, MA5 studi
- Detroit, MI5 studi
- Fort Worth, TX5 studi
- Austin, TX4 studi
- St. Louis, MO4 studi
- Irvine, CA4 studi
- Atlanta, GA4 studi
- Portland, OR4 studi
- Grand Rapids, MI4 studi
- Cleveland, OH4 studi
- Pittsburgh, PA4 studi
- Chicago, IL3 studi
- Coral Springs, FL3 studi
- Rochester, MN3 studi
- Omaha, NE3 studi
- San Francisco, CA3 studi
- Las Vegas, NV3 studi
- Fullerton, CA3 studi
- Orange, CA3 studi
- Irving, TX3 studi
- New Haven, CT3 studi
- Bridgeport, CT3 studi
- Seattle, WA3 studi
- Durham, NC3 studi
- Philadelphia, PA3 studi
Berdasarkan negara bagian
- Arizona6 studi
- California24 studi
- Connecticut4 studi
- Florida11 studi
- Georgia4 studi
- Illinois5 studi
- Massachusetts5 studi
- Michigan10 studi
- Minnesota5 studi
- Missouri5 studi
- Nebraska3 studi
- Nevada3 studi
- New Jersey5 studi
- New York14 studi
- North Carolina4 studi
- Ohio8 studi
- Oregon4 studi
- Pennsylvania8 studi
- Tennessee12 studi
- Texas19 studi
- Utah7 studi
- Virginia14 studi
- Washington6 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06780111A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07405151A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05319730Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06265285177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07189871A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07090499A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07085091A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07277413A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07229313Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06047379A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07730021A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07109726A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07217171Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06535607A Study of IDP-001 in Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07602842A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT07554521Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT06084481Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT04221893A Study of MGC026 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06242470A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06644781A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT05208762A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT06657144A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07224750Integrated Cf-miRNA and Exosomal miRNA Signature for Early Detection of Esophageal Squamous Cell Carcinoma
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07266363A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT04389632Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.